Mesoblast
MESO
37 hedge funds and large institutions have $7.81M invested in Mesoblast in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 8 closing their positions.
271% more call options, than puts
Call options by funds: $4.23M | Put options by funds: $1.14M
0.01% less ownership
Funds ownership: 0.26% → 0.24% (-0.01%)
12% less funds holding
Funds holding: 42 → 37 (-5)
19% less capital invested
Capital invested by funds: $9.62M → $7.81M (-$1.81M)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
62% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$634K |
| 2 |
TFA
Tobias Financial Advisors
Plantation,
Florida
|
+$85.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$79.9K |
| 4 |
SXL
Summit X LLC
Chesterfield,
Missouri
|
+$63K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$7.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$410K |
| 2 |
Goldman Sachs
New York
|
-$264K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$177K |
| 4 |
VF
Virtu Financial
New York
|
-$143K |
| 5 |
Jane Street
New York
|
-$128K |
MESO Hedge Fund Activity: Q1 2022 in Review
37 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q1 2022, worth a combined $7.81M — down 19% from $9.62M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MESO and 4 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 5 added.
The largest buyer was BlackRock, adding an estimated $634K. The largest seller was Morgan Stanley, cutting an estimated $410K.
- 37 institutional investors held Mesoblast (MESO) as of Q1 2022, down from 42 in Q4 2021.
- Funds reported $7.81M of Mesoblast stock for Q1 2022, down 19% quarter-over-quarter.
- 4 funds opened new Mesoblast positions in Q1 2022 and 8 closed out, a net change of -4 holders.
- The largest Mesoblast buyer in Q1 2022 was BlackRock, an estimated $634K added.
- The largest Mesoblast seller in Q1 2022 was Morgan Stanley, an estimated $410K sold.
Based on aggregated 13F filings for Q1 2022.